Cite
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
MLA
Alan Wells, et al. “Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.” Open Forum Infectious Diseases, vol. 8, no. 7, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....53cf9c79a5ee22aa04360a5bc7f2cf75&authtype=sso&custid=ns315887.
APA
Alan Wells, Maggie Blake, Mounzer Agha, Ghady Haidar, & Charles Chilleo. (2021). Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era. Open Forum Infectious Diseases, 8(7).
Chicago
Alan Wells, Maggie Blake, Mounzer Agha, Ghady Haidar, and Charles Chilleo. 2021. “Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.” Open Forum Infectious Diseases 8 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....53cf9c79a5ee22aa04360a5bc7f2cf75&authtype=sso&custid=ns315887.